Raymond James added Ocular Therapeutix (OCUL) to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from the firm’s equity analysts. An analyst may only have one “buy” idea on the list at any given time.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- Ocular Therapeutix initiated with an Outperform at RBC Capital
- Beam, Unity, Checkpoint, Inuvo, Ocular: Trending by Analysts
- Biotech Alert: Searches spiking for these stocks today
- Strategic Trial Adjustments and Efficiency Boost Ocular Therapeutix’s Prospects: A Buy Rating Justification
- Ocular Therapeutix initiated with a Buy at Needham
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue